recommended reading

HHS Bets on New Model to Fund Biodefense Drug Development


The Obama administration on Wednesday said it is putting down $40 million on a first-of-its-kind plan for a major drug maker to pursue an assortment of experimental bioterrorism antibiotics, drawing from a single funding pool as it studies newly discovered formulations and abandons any found to show little promise.

The approach is more flexible than the government's traditional strategy of funding specific drugs with individual contracts and "balances the business risk" for Washington and GlaxoSmithKline, the Health and Human Services Department said.

"Supporting development of multiple drug candidates simultaneously increases the likelihood that one or more will advance to the level at which the company can apply for U.S. Food and Drug Administration approval of the drug," according to an HHS press release. The department said the effort might yield treatments suitable for uses more routine than the dispersal of lethal bacteria by terrorists, potentially reducing the need for pricey federal stockpiling of new medicines.

The science of antibiotic development is unusually risky and complex, and "there has been a significant reduction in antibiotic research over the past 15 to 20 years," GlaxoSmithKline spokeswoman Melinda Stubbee told Global Security Newswire on Thursday. "The existing investment model for antibiotics is challenging and doesn’t adequately reward innovation in antibiotic research," she stated by e-mail.

The initial funding would cover 18 months and allow GlaxoSmithKline in part to pursue one developmental antibiotic already seen to be effective in fighting potential bioterror agents anthrax, plague and tularemia in animals, according to the HHS statement. Stubbee said the drug remains in a "very early" development phase and there is no timeline for it to complete the testing process and potentially go to market. She noted, though, that new antibiotics require an average of about a decade to reach consumers.

Decisions on which other prospective treatments will receive development funds will be made by a board of specialists from the company and the Health and Human Services Department's Biomedical Advanced Research and Development Authority. The North Carolina-based pharmaceutical firm declined to estimate how many drug development projects could ultimately receive financing under the plan.

The deal could provide up to $200 million over five years. Health and Human Services did not specify if it could pursue new deals based on the same approach, but said it is seeking more proposals for potential drugs effective against a wide variety of pathogens.

(Image via anyaivanova/

Threatwatch Alert

Network intrusion

FBI Warns Doctors, Dentists Their FTP Servers Are Targets

See threatwatch report


Close [ x ] More from Nextgov

Thank you for subscribing to newsletters from
We think these reports might interest you:

  • It’s Time for the Federal Government to Embrace Wireless and Mobility

    The United States has turned a corner on the adoption of mobile phones, tablets and other smart devices, outpacing traditional desktop and laptop sales by a wide margin. This issue brief discusses the state of wireless and mobility in federal government and outlines why now is the time to embrace these technologies in government.

  • Featured Content from RSA Conference: Dissed by NIST

    Learn more about the latest draft of the U.S. National Institute of Standards and Technology guidance document on authentication and lifecycle management.

  • A New Security Architecture for Federal Networks

    Federal government networks are under constant attack, and the number of those attacks is increasing. This issue brief discusses today's threats and a new model for the future.

  • Going Agile:Revolutionizing Federal Digital Services Delivery

    Here’s one indication that times have changed: Harriet Tubman is going to be the next face of the twenty dollar bill. Another sign of change? The way in which the federal government arrived at that decision.

  • Software-Defined Networking

    So many demands are being placed on federal information technology networks, which must handle vast amounts of data, accommodate voice and video, and cope with a multitude of highly connected devices while keeping government information secure from cyber threats. This issue brief discusses the state of SDN in the federal government and the path forward.

  • The New IP: Moving Government Agencies Toward the Network of The Future

    Federal IT managers are looking to modernize legacy network infrastructures that are taxed by growing demands from mobile devices, video, vast amounts of data, and more. This issue brief discusses the federal government network landscape, as well as market, financial force drivers for network modernization.


When you download a report, your information may be shared with the underwriters of that document.